Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients With Moderate to Severe Coronavirus Disease 2019: A Phase 2a Trial.

Sasson, Jennifer; Donlan, Alexandra N; Ma, Jennie Z; Haughey, Heather M; Coleman, Rachael; Nayak, Uma; Mathers, Amy J; Laverdure, Sylvain; Dewar, Robin; Jackson, Patrick E H; Heysell, Scott K; Sturek, Jeffrey M; Petri, William A

Sasson, Jennifer; Donlan, Alexandra N; Ma, Jennie Z; Haughey, Heather M; Coleman, Rachael; Nayak, Uma; Mathers, Amy J; Laverdure, Sylvain; Dewar, Robin; Jackson, Patrick E H; Heysell, Scott K; Sturek, Jeffrey M; Petri, William A.

Afiliação

Sasson J; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Donlan AN; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Ma JZ; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Haughey HM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Coleman R; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Nayak U; Center for Public Health Genomics and Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Mathers AJ; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Laverdure S; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, Maryland, USA.
Dewar R; Virus Isolation and Serology Laboratory, Frederick National Laboratory, Frederick, Maryland, USA.
Jackson PEH; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Heysell SK; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Sturek JM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.
Petri WA; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia, USA.

Open Forum Infect Dis ; 9(8): ofac343, 2022 Aug.

Article em En | MEDLINE | ID: mdl-35959207

Palavras-chave

COVID-19; IL-13; SARS-CoV-2; dupilumab; type 2 immunity

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google